Resistant Dextrin: What It Is, What the Evidence Says, and Whether It’s Good for You<\/title>\n<\/head>\n<body>\n\n<div class=\"bd-post\">\n<style>\n@import url('https:\/\/fonts.googleapis.com\/css2?family=Inter:wght@500;600;700&display=swap');\n\n.bd-post {\n --prose-width: 744px;\n --gap-normal: 32px;\n --gap-section: 48px;\n --pad-compact: 16px;\n --pad-standard: 24px;\n --body-bg: #FFFFFF;\n --text-primary: #000000;\n --text-secondary: #666666;\n --text-accent: #3D7A28;\n --card-fill: #F6FCEA;\n --card-border: #5C9647;\n --inverse-bg: #232E34;\n --inverse-text-primary: #FFFFFF;\n --inverse-text-secondary: #A0B0A0;\n --inverse-text-accent: #9FE125;\n --accent: #9FE125;\n --btn-white: #FFFFFF;\n --btn-ink: #232E34;\n --refs-text: #6E6E6E;\n --refs-link: #2A76B4;\n font-family: \"Inter\", sans-serif;\n font-size: 16px;\n font-weight: 500;\n line-height: 1.5;\n color: var(--text-primary);\n background: var(--body-bg);\n padding: 40px;\n max-width: 100%;\n box-sizing: border-box;\n}\n.bd-post a { overflow-wrap: anywhere; word-break: break-word; }\n.bd-post p a, .bd-post li a, .bd-post blockquote a, .bd-post td a { color: var(--text-accent); text-decoration: underline; }\n.bd-post p, .bd-post li { overflow-wrap: break-word; }\n.bd-post .bd-post-article { max-width: var(--prose-width); margin: 0 auto; }\n\n\/* PROSE SPACING *\/\n.bd-post p { margin: 0 0 1em; }\n.bd-post h1 { font-family: \"Inter\", sans-serif; font-weight: 600; font-size: 50px; line-height: 1.2; color: var(--text-primary); margin: 0 0 16px; }\n.bd-post h2 { font-family: \"Inter\", sans-serif; font-weight: 600; font-size: 45px; line-height: 1.2; color: var(--text-primary); margin: 48px 0 16px; }\n.bd-post h3 { font-family: \"Inter\", sans-serif; font-weight: 600; font-size: 28px; line-height: 1.2; color: var(--text-primary); margin: 32px 0 12px; }\n.bd-post ul, .bd-post ol { margin: 0 0 1em; padding-left: 1.5em; }\n.bd-post li { margin-bottom: 0.5em; }\n.bd-post strong { font-weight: 700; }\n\n\/* box-sizing catch-all only *\/\n.bd-post [class*=\"bp-\"] { box-sizing: border-box; }\n.bd-post [class*=\"rich-\"] { box-sizing: border-box; }\n\n\/* BP outer margins \u2014 per-class explicit *\/\n.bd-post .bd-post-article > .bp-1-verdict { margin: var(--gap-normal) 0; }\n.bd-post .bd-post-article > .bp-2-juris { margin: var(--gap-normal) 0; }\n.bd-post .bd-post-article > .bp-cta-end { margin: var(--gap-section) 0; }\n.bd-post .bd-post-article > .table-wrapper { margin: var(--gap-normal) 0; }\n.bd-post .bd-post-article > .rich-callout { margin: var(--gap-normal) 0; }\n.bd-post .bd-post-article > .rich-checklist { margin: var(--gap-normal) 0; }\n\n\/* ---------- BP-1 verdict signature card ---------- *\/\n.bd-post .bp-1-verdict {\n background: var(--card-fill);\n border: 1.5px solid var(--card-border);\n border-radius: 20px 0 20px 0;\n box-shadow: 5px 5px 0 var(--accent);\n padding: var(--pad-standard);\n}\n.bd-post .bp-1-eyebrow { font-size: 13px; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--text-accent); margin: 0 0 8px; }\n.bd-post .bp-1-title { font-size: 24px; font-weight: 600; line-height: 1.25; color: var(--text-primary); margin: 0 0 12px; }\n.bd-post .bp-1-ticon { display: inline-flex; vertical-align: -0.2em; margin-right: 10px; }\n.bd-post .bp-1-ticon svg { width: 24px; height: 24px; }\n.bd-post .bp-1-body { font-size: 16px; line-height: 1.6; color: var(--text-primary); margin: 0 0 16px; }\n.bd-post .bp-1-chips { display: flex; flex-wrap: wrap; gap: 10px; margin: 0 0 16px; }\n.bd-post .bp-1-chip {\n display: inline-flex; align-items: center; gap: 6px;\n background: var(--body-bg);\n border: 1px solid var(--card-border);\n border-radius: 999px;\n padding: 6px 12px;\n font-size: 12px; font-weight: 600; letter-spacing: 0.06em; text-transform: uppercase;\n color: var(--text-accent);\n}\n.bd-post .bp-1-chip svg { width: 14px; height: 14px; }\n.bd-post .bp-1-source { font-size: 12px; line-height: 1.5; color: var(--text-secondary); border-top: 1px solid var(--card-border); padding: var(--pad-compact) 0 0; }\n\n\/* ---------- BP-2 jurisdictions grid ---------- *\/\n.bd-post .bp-2-juris {\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-radius: 20px;\n padding: var(--pad-standard);\n}\n.bd-post .bp-2-jtitle { font-size: 20px; font-weight: 600; line-height: 1.25; color: var(--text-primary); margin: 0 0 16px; }\n.bd-post .bp-2-ticon { display: inline-flex; vertical-align: -0.2em; margin-right: 10px; }\n.bd-post .bp-2-ticon svg { width: 22px; height: 22px; }\n.bd-post .bp-2-grid { display: grid; grid-template-columns: repeat(4, 1fr); gap: 16px; margin: 0 0 16px; }\n.bd-post .bp-2-cell {\n background: var(--body-bg);\n border: 1px solid var(--card-border);\n border-radius: 10px;\n padding: 16px;\n}\n.bd-post .bp-2-region { display: block; font-size: 13px; font-weight: 600; letter-spacing: 0.06em; text-transform: uppercase; color: var(--text-accent); margin: 0 0 8px; }\n.bd-post .bp-2-text { font-size: 14px; line-height: 1.6; color: var(--text-primary); }\n.bd-post .bp-2-source { font-size: 12px; line-height: 1.5; color: var(--text-secondary); border-top: 1px solid var(--card-border); padding: var(--pad-compact) 0 0; }\n\n\/* ---------- CTA end ---------- *\/\n.bd-post .bp-cta-end {\n background: var(--inverse-bg);\n border-radius: 20px;\n padding: var(--pad-standard);\n color: var(--inverse-text-primary);\n display: flex;\n flex-direction: column;\n align-items: center;\n text-align: center;\n}\n.bd-post .bp-cta-end-title { font-size: 26px; font-weight: 600; line-height: 1.25; color: var(--inverse-text-primary); margin: 0 0 12px; }\n.bd-post .bp-cta-end-ticon { display: inline-flex; vertical-align: -0.2em; margin-right: 10px; }\n.bd-post .bp-cta-end-ticon svg { width: 22px; height: 22px; color: var(--inverse-text-accent); }\n.bd-post .bp-cta-end-sub { max-width: 680px; font-size: 15px; line-height: 1.6; color: var(--inverse-text-secondary); margin: 0 0 20px; }\n.bd-post .bp-cta-end-btn {\n display: inline-flex; align-items: center; gap: 8px;\n background: var(--accent);\n color: var(--btn-ink);\n border-radius: 999px;\n padding: 15px 28px;\n font-family: \"Inter\", sans-serif;\n font-size: 16px; font-weight: 600; line-height: 1.2;\n text-decoration: none;\n transition: transform .2s ease-out, background .2s ease-out, color .2s ease-out;\n}\n.bd-post .bp-cta-end-btn:hover { background: var(--btn-white); color: var(--btn-ink); transform: translateY(-2px); }\n.bd-post .bp-cta-end-btn svg { width: 18px; height: 18px; }\n\n\/* ---------- rich: tables ---------- *\/\n.bd-post .table-wrapper { overflow-x: auto; }\n.bd-post .rich-table { border-collapse: collapse; width: 100%; }\n.bd-post .rich-table th {\n text-align: left; vertical-align: top;\n font-size: 14px; font-weight: 600; line-height: 1.4; color: var(--text-primary);\n background: transparent;\n border-bottom: 2px solid var(--card-border);\n padding: 10px 12px;\n}\n.bd-post .rich-table td {\n font-size: 15px; line-height: 1.5; color: var(--text-primary);\n border-bottom: 1px solid var(--card-border);\n padding: 12px;\n vertical-align: top;\n}\n.bd-post .rich-table td:first-child { font-weight: 600; }\n.bd-post .rich-source { font-size: 12px; line-height: 1.5; color: var(--text-secondary); border-top: 1px solid var(--card-border); padding: var(--pad-compact) 0 0; margin-top: 2px; }\n\n\/* ---------- rich: callout (info) ---------- *\/\n.bd-post .rich-callout {\n display: flex; align-items: flex-start; gap: 16px;\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-left: 3px solid var(--text-accent);\n border-radius: 10px;\n padding: var(--pad-compact);\n}\n.bd-post .rich-callout-icon { flex: 0 0 auto; display: inline-flex; }\n.bd-post .rich-callout-icon svg { width: 22px; height: 22px; color: var(--text-accent); }\n.bd-post .rich-callout-body { flex: 1 1 auto; min-width: 0; }\n.bd-post .rich-callout-text { font-size: 15px; line-height: 1.6; color: var(--text-primary); }\n.bd-post .rich-callout-source { font-size: 12px; line-height: 1.5; color: var(--text-secondary); border-top: 1px solid var(--card-border); padding: var(--pad-compact) 0 0; margin-top: 12px; }\n\n\/* ---------- rich: checklist ---------- *\/\n.bd-post .rich-checklist {\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-radius: 20px;\n padding: var(--pad-standard);\n}\n.bd-post .rich-checklist-title { font-size: 20px; font-weight: 600; line-height: 1.25; color: var(--text-primary); margin: 0 0 16px; }\n.bd-post .rich-checklist-ticon { display: inline-flex; vertical-align: -0.2em; margin-right: 10px; }\n.bd-post .rich-checklist-ticon svg { width: 22px; height: 22px; color: var(--text-accent); }\n.bd-post .rich-checklist-grid { display: grid; grid-template-columns: repeat(2, 1fr); gap: 24px; margin: 0 0 16px; }\n.bd-post .rich-checklist-head { font-size: 17px; font-weight: 600; color: var(--text-primary); margin: 0 0 10px; }\n.bd-post .rich-checklist-item { display: flex; align-items: flex-start; gap: 8px; margin: 0 0 8px; }\n.bd-post .rich-checklist-item svg { flex: 0 0 auto; width: 16px; height: 16px; color: var(--text-accent); margin-top: 3px; }\n.bd-post .rich-checklist-item div { font-size: 15px; line-height: 1.6; color: var(--text-primary); }\n.bd-post .rich-checklist-source { font-size: 12px; line-height: 1.5; color: var(--text-secondary); border-top: 1px solid var(--card-border); padding: var(--pad-compact) 0 0; }\n\n\/* ---------- references ---------- *\/\n.bd-post .bd-refs { margin: var(--gap-section) 0 0; border-top: 1px solid var(--card-border); font-weight: 400; }\n.bd-post .bd-refs h2 { font-size: 28px; margin: 48px 0 16px; }\n.bd-post .bd-refs ol { margin: 0; padding-left: 1.5em; }\n.bd-post .bd-refs li { font-size: 14px; line-height: 1.5; color: var(--text-secondary); overflow-wrap: anywhere; word-break: break-word; }\n\n\/* ---------- motion ---------- *\/\n@media (prefers-reduced-motion: no-preference) {\n @supports (animation-timeline: view()) {\n .bd-post .bd-reveal { animation: bd-fade-in linear both; animation-timeline: view(); animation-range: entry 0% entry 35%; }\n @keyframes bd-fade-in { from { opacity: 0; } to { opacity: 1; } }\n }\n .bd-post h2 { transition: color .2s ease-out, transform .2s ease-out; transform-origin: left; }\n .bd-post h2:hover { color: var(--text-accent); transform: scale(1.01); }\n .bd-post .bp-cta-end-btn { transition: transform .2s ease-out, background .2s ease-out, color .2s ease-out; }\n .bd-post .bd-post-article a { transition: color .2s ease-out; }\n}\n\n\/* ---------- mobile ---------- *\/\n@media (max-width: 768px) {\n .bd-post { padding: 16px; }\n .bd-post h1 { font-size: 32px; }\n .bd-post h2 { font-size: 30px; margin-top: 32px; }\n .bd-post h3 { font-size: 20px; margin-top: 24px; }\n .bd-post .bd-refs h2 { font-size: 22px; }\n .bd-post .bp-1-title { font-size: 20px; }\n .bd-post .bp-1-title svg { width: 20px; height: 20px; }\n .bd-post .bp-cta-end-title { font-size: 20px; }\n .bd-post .bp-cta-end-ticon svg { width: 18px; height: 18px; }\n .bd-post .bp-2-grid { grid-template-columns: repeat(2, 1fr); }\n .bd-post .rich-checklist-grid { grid-template-columns: 1fr; }\n \/* tables stack *\/\n .bd-post .rich-table thead { display: none; }\n .bd-post .rich-table tbody tr { display: block; border: 1px solid var(--card-border); border-radius: 8px; overflow: hidden; margin: 0 0 12px; }\n .bd-post .rich-table td { display: block; width: 100%; border-bottom: 1px solid var(--card-border); padding: 10px 15px; box-sizing: border-box; }\n .bd-post .rich-table td:last-child { border-bottom: 0; }\n .bd-post .rich-table td::before {\n content: attr(data-label);\n display: block;\n font-size: 13px; font-weight: 700; letter-spacing: .04em; text-transform: uppercase;\n color: var(--text-secondary);\n margin: 0 0 4px;\n }\n .bd-post .rich-table td:first-child { background: var(--card-fill); }\n .bd-post .rich-table td:first-child::before { content: none; }\n}\n\/* NO dark-mode block: light-only deployment *\/\n<\/style>\n<article class=\"bd-post-article\">\n\n<p>You have probably met resistant dextrin without noticing. It appears on labels as soluble corn fiber, soluble tapioca fiber, resistant maltodextrin, or, in Asia-Pacific markets, indigestible dextrin. Because the word “dextrin” sits in several of those names, a fair number of shoppers quietly wonder whether this is just maltodextrin wearing a disguise. It is not, and the difference matters. But the more interesting question is the one the marketing rarely answers precisely: which of the claimed benefits are actually proven, at what dose, and for whom. This article walks the ingredient through the body, then grades the evidence claim by claim. That way you can decide what resistant dextrin can honestly do for you, or for a product you are developing.<\/p>\n\n<h2>What Resistant Dextrin Is, and Where It Sits in the Dextrin Family<\/h2>\n<p>Start with the family tree, because the confusion is a naming problem before it is a nutrition problem. All of these ingredients begin as starch. Heat that starch with a food-grade acid or enzyme and it breaks into shorter glucose chains called dextrins. Keep going and you get maltodextrin, the fully digestible, high-glycemic filler that snack critics love to hate. Resistant dextrin takes the process one step further. The chains are re-linked with new bond types, including \u03b2-1,6 and \u03b2-1,2 bonds, that human small-intestinal enzymes cannot easily cut (<a href=\"https:\/\/prebioticassociation.org\/prebiotic-type-spotlight-resistant-dextrin\/\">Global Prebiotic Association<\/a>, 2024). Same feedstock, opposite behavior.<\/p>\n<p>Resistant starch, a name that appears in the same conversations, is a different ingredient entirely: it escapes digestion through physical structure rather than chemical re-linking. Similar gut outcome, different molecule.<\/p>\n<p>Once you know the family, the alias map makes sense. “Resistant maltodextrin” and “indigestible dextrin” describe the same ingredient class. The latter term dominates in Japan, where it is an approved functional ingredient in “foods for specified health use” (<a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\">Otsuka Pharmaceutical<\/a>). “Soluble corn fiber” and “soluble tapioca fiber” are the US label names, referencing the starch source.<\/p>\n<p>What the body does with it explains why it counts as fiber at all. Roughly 15% is digested in the small intestine. About 75% reaches the colon and ferments slowly there. The remaining 10% passes out (<a href=\"https:\/\/prebioticassociation.org\/prebiotic-type-spotlight-resistant-dextrin\/\">Global Prebiotic Association<\/a>, 2024, citing Shamasbi et al. 2019). That colonic journey, not the glucose backbone, is where every claimed benefit begins.<\/p>\n\n<div class=\"table-wrapper bd-reveal\">\n<table class=\"rich-table\">\n<thead><tr><th>Name<\/th><th>What it is<\/th><th>Digestive behavior<\/th><th>Where you meet it<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>Dextrin<\/td><td data-label=\"What it is\">Short glucose chains from heated starch<\/td><td data-label=\"Digestive behavior\">Largely digestible<\/td><td data-label=\"Where you meet it\">Glues, browning on baked surfaces<\/td><\/tr>\n<tr><td>Maltodextrin<\/td><td data-label=\"What it is\">Enzymatically converted starch, graded by DE value<\/td><td data-label=\"Digestive behavior\">Fully digestible, high glycemic impact<\/td><td data-label=\"Where you meet it\">Bulking and texture in processed foods<\/td><\/tr>\n<tr><td>Resistant dextrin<\/td><td data-label=\"What it is\">Re-polymerized starch fiber with new bond types<\/td><td data-label=\"Digestive behavior\">About 15% digested; 75% colonic fermentation; 10% excreted<\/td><td data-label=\"Where you meet it\">Fiber-fortified bars, drinks, keto products<\/td><\/tr>\n<tr><td>Resistant starch<\/td><td data-label=\"What it is\">Physically protected starch granules<\/td><td data-label=\"Digestive behavior\">Escapes digestion structurally<\/td><td data-label=\"Where you meet it\">Cooled potatoes, green bananas, RS2\/RS3 ingredients<\/td><\/tr>\n<\/tbody>\n<\/table>\n<div class=\"rich-source\">Source: Global Prebiotic Association (2024); Otsuka Pharmaceutical; Wikipedia (dextrin overview)<\/div>\n<\/div>\n\n<h2>The Journey: What Your Body Does With Resistant Dextrin<\/h2>\n<p>The colonic 75% is not passive transit. It is fuel, and the list of downstream effects follows directly from how that fuel gets used.<\/p>\n<h3>In the colon: fermentation, short-chain fatty acids, and that gassy first week<\/h3>\n<p>Gut bacteria ferment resistant dextrin into short-chain fatty acids, and the fermentation is selective. Studies report increases in beneficial genera such as Bacteroides and Parabacteroides alongside reductions in Clostridium perfringens (<a href=\"https:\/\/prebioticassociation.org\/prebiotic-type-spotlight-resistant-dextrin\/\">Global Prebiotic Association<\/a>, 2024, citing Thirion et al. 2022). Fermentation produces gas as a byproduct, which is why fiber newcomers often feel bloated in the first days. The same controlled trial tracked this adaptation. The microbiota shifts toward lower-gas fermentation pathways over time, so the early discomfort typically recedes (<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9654059\/\">Barber et al.<\/a>, 2022).<\/p>\n\n<div class=\"rich-callout bd-reveal\">\n<span class=\"rich-callout-icon\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"M12 16v-4\"\/><path d=\"M12 8h.01\"\/><\/svg><\/span>\n<div class=\"rich-callout-body\">\n<div class=\"rich-callout-text\">Expect an adjustment window. Gas and bloating in the first one to two weeks are a normal fermentation response for most people, not a sign the ingredient is wrong for you. Ramp up the dose gradually and they usually settle.<\/div>\n<div class=\"rich-callout-source\">Source: Barber et al. 2022 (Nutrients, PMC9654059); r\/Microbiome community reports on fiber adaptation<\/div>\n<\/div>\n<\/div>\n<h3>Blood sugar: a flatter curve by slowing maltose digestion<\/h3>\n<p>Resistant dextrin does not block glucose absorption. Its documented mechanism is narrower and more elegant: it slows the digestion of maltose, the double sugar that starch breaks into. Taken with a meal, that flattens the post-meal glucose rise. Japanese trials summarized by Otsuka found no effect on glucose or fructose itself. They did find significant suppression of the blood sugar rise when five grams were taken with a noodle meal (<a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\">Otsuka Pharmaceutical<\/a>). In people with type 2 diabetes, longer supplementation has translated into measurable insulin-resistance improvements, a point the next section grades.<\/p>\n<h3>Blood fats and visceral fat<\/h3>\n<p>The same slowing effect extends to fat. Taken with meals, resistant dextrin blunts the post-meal triglyceride rise. In a 12-week trial, 36 overweight men drank tea with nine grams of indigestible dextrin daily. Compared with the plain-tea group, they showed significant decreases in visceral fat area and triglycerides (<a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\">Otsuka Pharmaceutical<\/a>, citing Obesity Research, 2007).<\/p>\n\n <img decoding=\"async\" src=\"https:\/\/www.saigaoingredients.com\/wp-content\/uploads\/2026\/09\/Resistant-Dextrin-1.webp\" style=\"width: 512px; height: 384px; max-width: 100%; object-fit: cover; border-radius: 12px; margin: 30px auto; display: block; box-shadow: 10px 10px 60px 0px rgba(210, 221, 224, 0.35); transition: all 0.3s ease; cursor: pointer;\" onmouseover=\"this.style.transform='translateY(-5px) scale(1.03)'; this.style.boxShadow='15px 25px 80px 0px rgba(210, 221, 224, 0.45)'\" onmouseout=\"this.style.transform='translateY(0) scale(1)'; this.style.boxShadow='10px 10px 60px 0px rgba(210, 221, 224, 0.35)'\"> \n\n<h3>Fullness and minerals<\/h3>\n<p>Two quieter effects round out the journey. On satiety, a controlled study in healthy adults found resistant dextrin modified fullness and glycemic responses, though the authors were explicit that long-term weight effects need more study (<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8572182\/\">Hobden et al.<\/a>, 2021). Separate work found breakfast intake blunted the hunger hormone ghrelin’s rise before lunch. On minerals, fermentation acids appear to improve uptake of calcium, magnesium, iron, and zinc. In one trial, young women with low serum iron took 15 grams daily for four weeks, and their iron status improved (<a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\">Otsuka Pharmaceutical<\/a>).<\/p>\n\n<h2>Is Resistant Dextrin Good for You? Grading the Evidence<\/h2>\n<p>Here is where the sources diverge. Industry summaries list a dozen benefits; medical consumer sites call the evidence inconclusive. Both camps are looking at the same literature. The difference is grading: the benefits are not equally proven, and once you sort them into tiers, the contradiction dissolves.<\/p>\n<h3>What is well proven<\/h3>\n<p>Two randomized controlled trials anchor the strong tier. In women with type 2 diabetes, ten grams of resistant dextrin daily for eight weeks significantly improved insulin resistance and inflammation markers versus placebo (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27028002\/\">Aliasgharzadeh et al.<\/a>, 2015). In overweight men, supplementation improved insulin resistance and determinants of metabolic syndrome and was well tolerated (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21164548\/\">Li et al.<\/a>, 2010).<\/p>\n<p>Safety runs deep, too. A 16-week study took ten grams three times daily and found no adverse physiological changes. Serum protein and minerals, including calcium, magnesium, and iron, stayed stable (<a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\">Otsuka Pharmaceutical<\/a>, citing the Japanese Journal of Clinical Nutrition, 1993).<\/p>\n<h3>What is promising but not settled<\/h3>\n<p>Satiety and weight sit here. The 2021 healthy-adult trial found fullness responses modified but flagged the need for long-term data (<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8572182\/\">Hobden et al.<\/a>, 2021). An earlier trial found no appetite effect at all, a split that medical reviewers read honestly as unsettled (<a href=\"https:\/\/www.everydayhealth.com\/nutrients-supplements\/psyllium-vs-wheat-dextrin\/\">Everyday Health<\/a>, 2026). Blood-lipid improvement likewise remains inconclusive in review articles. Note a subtlety much of the skeptical coverage misses: the cautious verdicts often concern wheat dextrin, the common supplement fiber, not resistant dextrin specifically. Related, but a different molecule with its own thinner evidence file.<\/p>\n<h3>How much: the dose windows<\/h3>\n<p>Dose is where most real-world disappointment lives, because benefit thresholds and comfort ceilings are different numbers. For planning purposes, the working dose map looks like this. Gut-microbiota effects show dose response from 5 to 20 g\/day (<a href=\"https:\/\/prebioticassociation.org\/prebiotic-type-spotlight-resistant-dextrin\/\">Global Prebiotic Association<\/a>, 2024, citing Thirion et al. 2022). Satiety studies cluster at 8 to 14 g\/day, and the metabolic trials used 10 g\/day. Short-term tolerance extends to 50 g\/day in divided doses (Marteau et al. 2011, via the same review). Food-formulation studies have accommodated 20 to 25% of product composition without undesirable effects (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15220947\/\">van den Heuvel et al.<\/a>, 2004).<\/p>\n\n<div class=\"bp-1-verdict bd-reveal\">\n<div class=\"bp-1-eyebrow\">The evidence, graded<\/div>\n<div class=\"bp-1-title\"><span class=\"bp-1-ticon\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><polygon points=\"12 2 2 7 12 12 22 7 12 2\"\/><polyline points=\"2 17 12 22 22 17\"\/><polyline points=\"2 12 12 17 22 12\"\/><\/svg><\/span>Three Evidence Tiers, One Ingredients List<\/div>\n<div class=\"bp-1-body\">Its benefits are real but not equally proven. Insulin-resistance improvement at 10 g\/day in type 2 diabetes is randomized-trial evidence; “lowers blood lipids” is still graded inconclusive.<\/div>\n<div class=\"bp-1-chips\">\n<span class=\"bp-1-chip\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg>Proven<\/span>\n<span class=\"bp-1-chip\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><polyline points=\"22 7 13.5 15.5 8.5 10.5 2 17\"\/><polyline points=\"16 7 22 7 22 13\"\/><\/svg>Promising<\/span>\n<span class=\"bp-1-chip\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"M9.09 9a3 3 0 0 1 5.83 1c0 2-3 3-3 3\"\/><path d=\"M12 17h.01\"\/><\/svg>Inconclusive<\/span>\n<\/div>\n<div class=\"bp-1-source\">Source: Aliasgharzadeh 2015 (PMID 27028002); Everyday Health evidence review 2026<\/div>\n<\/div>\n<p>Placed side by side, the outcomes grade cleanly. The table below is the one worth keeping: it is the difference between a claim that survives scrutiny and one that quietly overpromises.<\/p>\n\n<div class=\"table-wrapper bd-reveal\">\n<table class=\"rich-table\">\n<thead><tr><th>Outcome<\/th><th>Evidence tier<\/th><th>Key population and dose<\/th><th>When it falls short or needs care<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>Insulin resistance and inflammation (type 2 diabetes)<\/td><td data-label=\"Evidence tier\">Proven: randomized controlled trials<\/td><td data-label=\"Key population and dose\">Women with T2D, 10 g\/day for 8 weeks<\/td><td data-label=\"When it falls short or needs care\">Trial population was T2D women; extrapolate cautiously<\/td><\/tr>\n<tr><td>Metabolic syndrome markers<\/td><td data-label=\"Evidence tier\">Proven: randomized controlled trial<\/td><td data-label=\"Key population and dose\">Overweight men, daily supplementation<\/td><td data-label=\"When it falls short or needs care\">Well tolerated in trial; longer-term data thinner<\/td><\/tr>\n<tr><td>Post-meal blood sugar<\/td><td data-label=\"Evidence tier\">Proven mechanism, human confirmation<\/td><td data-label=\"Key population and dose\">Taken with maltose\/starch meals, 5 g and up<\/td><td data-label=\"When it falls short or needs care\">Does not block glucose itself; effects depend on the meal<\/td><\/tr>\n<tr><td>Visceral fat and triglycerides<\/td><td data-label=\"Evidence tier\">Promising<\/td><td data-label=\"Key population and dose\">Overweight men, 9 g\/day for 12 weeks<\/td><td data-label=\"When it falls short or needs care\">Single trial; grade as supportive, not settled<\/td><\/tr>\n<tr><td>Satiety and weight management<\/td><td data-label=\"Evidence tier\">Promising but split<\/td><td data-label=\"Key population and dose\">Healthy adults; doses from 8 to 14 g\/day<\/td><td data-label=\"When it falls short or needs care\">One trial positive, one null; long-term weight data lacking<\/td><\/tr>\n<tr><td>Gut microbiota and regularity<\/td><td data-label=\"Evidence tier\">Proven mechanism, doses mapped<\/td><td data-label=\"Key population and dose\">5 to 20 g\/day shows dose response<\/td><td data-label=\"When it falls short or needs care\">First 1 to 2 weeks of gas are adaptation, not failure<\/td><\/tr>\n<tr><td>Mineral absorption<\/td><td data-label=\"Evidence tier\">Early stage<\/td><td data-label=\"Key population and dose\">Animal data plus one 15 g\/day human trial<\/td><td data-label=\"When it falls short or needs care\">Human evidence base is small<\/td><\/tr>\n<tr><td>General blood-lipid lowering<\/td><td data-label=\"Evidence tier\">Inconclusive<\/td><td data-label=\"Key population and dose\">Reviews of mixed dextrin evidence<\/td><td data-label=\"When it falls short or needs care\">Do not put this on a product claim yet<\/td><\/tr>\n<\/tbody>\n<\/table>\n<div class=\"rich-source\">Source: Aliasgharzadeh 2015 (PMID 27028002); Li 2010 (PMID 21164548); Hobden 2021; Barber 2022; Otsuka; Everyday Health 2026<\/div>\n<\/div>\n<p>The practical rule every trial repeats: start low, ramp up over a couple of weeks, and let the microbiota adapt.<\/p>\n<h3>Who should be careful<\/h3>\n<p>Three groups deserve explicit notes. People with celiac disease or gluten sensitivity must check the starch source before assuming any dextrin is safe, because wheat-derived dextrin can carry gluten. Corn- and tapioca-based resistant dextrin is naturally gluten-free, so source documentation settles the question (<a href=\"https:\/\/www.everydayhealth.com\/nutrients-supplements\/psyllium-vs-wheat-dextrin\/\">Everyday Health<\/a>, 2026). People with inflammatory bowel disease or a history of intestinal blockages should talk to a clinician before adding any fermentable fiber. And for pregnant women and young children, the trial base is thin; absence of evidence is not evidence of harm, but it is also not a green light.<\/p>\n<p>So, is it good for you? For most people, at realistic doses, the honest answer is yes with precision. The metabolic and gut benefits are genuinely documented. The size of the promise should match the tier of evidence, and the dose should match the goal.<\/p>\n\n<h2>From Evidence to Product: Rules, Sources, and Forms<\/h2>\n<p>If you are building with this ingredient rather than eating it, the same evidence tiers become the boundary of what you can honestly claim. Three practical axes decide the fit.<\/p>\n<p>The regulatory footing is established across major markets, with different mechanics in each.<\/p>\n\n<div class=\"bp-2-juris bd-reveal\">\n<div class=\"bp-2-jtitle\"><span class=\"bp-2-ticon\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"M12 2a14.5 14.5 0 0 0 0 20 14.5 14.5 0 0 0 0-20\"\/><path d=\"M2 12h20\"\/><\/svg><\/span>One Ingredient, Four Regulatory Footings<\/div>\n<div class=\"bp-2-grid\">\n<div class=\"bp-2-cell\"><span class=\"bp-2-region\">United States<\/span><div class=\"bp-2-text\">Meets the FDA’s dietary fiber definition; widely supplied under GRAS notifications.<\/div><\/div>\n<div class=\"bp-2-cell\"><span class=\"bp-2-region\">European Union<\/span><div class=\"bp-2-text\">EFSA’s 2014 scientific opinion found the ingredient sufficiently characterized, with an assessed pathway for post-meal glycemic claims.<\/div><\/div>\n<div class=\"bp-2-cell\"><span class=\"bp-2-region\">Canada<\/span><div class=\"bp-2-text\">Accepted on Health Canada’s list of reviewed dietary fibres as a novel fibre.<\/div><\/div>\n<div class=\"bp-2-cell\"><span class=\"bp-2-region\">Japan<\/span><div class=\"bp-2-text\">Approved as a functional ingredient in “foods for specified health use” (FOSHU).<\/div><\/div>\n<\/div>\n<div class=\"bp-2-source\">Source: Global Prebiotic Association 2024; EFSA Journal 2014;12(10):3839; Health Canada fibre list<\/div>\n<\/div>\n<p>Formulation-wise, the starch source is a specification, not a detail. Wheat-derived material needs gluten handling for sensitive markets; corn- and tapioca-based grades are naturally gluten-free, which is why most global supply runs on those two sources. Grade matters next. A typical 90% corn-based resistant dextrin powder specification publishes total dietary fiber at \u226590.0% on a dry basis. 70% grades trade fiber density for cost in applications where the claim does not need to be maximal (<a href=\"https:\/\/www.saigaoingredients.com\/products\/90-corn-resistant-dextrin-powder-soluble-corn-fiber-powder\/\">example 90% grade specification<\/a>). Form follows the application. Powders meter and store well for bars and blends; syrups bind and sweeten in one stroke for bars and beverages. Low viscosity, a near-transparent solution, and heat and acid stability are what make the ingredient beverage-friendly (<a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\">Otsuka Pharmaceutical<\/a>). The market context supports the build-out. Analysts sized the global resistant dextrin market at $382.9 million in 2022, projecting $752.64 million by 2031, a 7.8% CAGR (Business Research Insights, as compiled by the <a href=\"https:\/\/prebioticassociation.org\/prebiotic-type-spotlight-resistant-dextrin\/\">Global Prebiotic Association<\/a>).<\/p>\n\n<h2>What This Means for Your Product Program<\/h2>\n<p>Everything above compresses into two operating positions, depending on which side of the transaction you sit on.<\/p>\n<p>If you are developing a functional food, beverage, or supplement: build the product story on the proven tier. Insulin-resistance and metabolic-syndrome outcomes, gut-microbiota effects, and meal-context blood sugar support are all defensible with citations. Treat weight management and lipid claims as direction, not promise, until the literature firms up. And invest in the education most brands skip. Telling consumers about the one-to-two-week adaptation window, and explaining the dextrin family in your own packaging copy, pre-empts both the “maltodextrin in disguise” suspicion and the bloated-week-one one-star review.<\/p>\n<p>If you are a distributor or importer stocking the category: growth projections justify the shelf space, but supplier quality decides whether it stays. Three questions separate professional suppliers from the rest, and they map directly to this article. One: what fiber percentage, on what grade and dry-basis basis, backed by which documentation. Two: what starch source, with gluten status stated. Three: what batch-to-batch consistency data and certification file comes with the shipment.<\/p>\n\n<div class=\"rich-checklist bd-reveal\">\n<div class=\"rich-checklist-title\"><span class=\"rich-checklist-ticon\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"m3 17 2 2 4-4\"\/><path d=\"m3 7 2 2 4-4\"\/><path d=\"M13 6h8\"\/><path d=\"M13 12h8\"\/><path d=\"M13 18h8\"\/><\/svg><\/span>Your Operating Checklists<\/div>\n<div class=\"rich-checklist-grid\">\n<div>\n<div class=\"rich-checklist-head\">For brand and product teams<\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Anchor claims to proven-tier outcomes (insulin resistance, metabolic syndrome markers, microbiota, meal-context glycemia)<\/div><\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Keep weight and lipid messaging at “emerging evidence” strength<\/div><\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Put the adaptation window in onboarding copy and FAQs<\/div><\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Name the ingredient’s family and aliases on pack to defuse the maltodextrin confusion<\/div><\/div>\n<\/div>\n<div>\n<div class=\"rich-checklist-head\">For distributors and importers<\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Require fiber content with grade and dry-basis basis in writing<\/div><\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Confirm starch source and gluten-free status per lot specification<\/div><\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Demand batch-consistency data and certification documentation (non-GMO, Kosher, Halal as applicable)<\/div><\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Use the three-tier evidence framing when training downstream sales teams<\/div><\/div>\n<\/div>\n<\/div>\n<div class=\"rich-checklist-source\">Source: Evidence tiers per this article’s Sections 3-4; supplier documentation practice per published specification sheets<\/div>\n<\/div>\n\n<div class=\"bp-cta-end bd-reveal\">\n<div class=\"bp-cta-end-title\"><span class=\"bp-cta-end-ticon\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M5 12h14\"\/><path d=\"m12 5 7 7-7 7\"\/><\/svg><\/span>Source Resistant Dextrin With the Paperwork to Back It<\/div>\n<div class=\"bp-cta-end-sub\">SAIGAO supplies corn- and tapioca-based resistant dextrin as powder or syrup, in 70% and 90% grades. Ask for the specification sheet, the method note behind the fiber number, and batch-consistency data, with free samples within limits and replies to international inquiries inside 12 hours.<\/div>\n<a class=\"bp-cta-end-btn\" href=\"https:\/\/www.saigaoingredients.com\/contact\/\" target=\"_self\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M5 12h14\"\/><path d=\"m12 5 7 7-7 7\"\/><\/svg>Request Specs & Samples<\/a>\n<\/div>\n\n<div class=\"bd-refs\">\n<h2>References<\/h2>\n<ol>\n<li>Global Prebiotic Association. “Prebiotic Type Spotlight: Resistant Dextrin.” 2024. <a href=\"https:\/\/prebioticassociation.org\/prebiotic-type-spotlight-resistant-dextrin\/\" target=\"_blank\" rel=\"noopener\">prebioticassociation.org<\/a><\/li>\n<li>Aliasgharzadeh, A. et al. “Resistant dextrin, as a prebiotic, improves insulin resistance and inflammation in women with type 2 diabetes: a randomised controlled clinical trial.” British Journal of Nutrition, 2015. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27028002\/\" target=\"_blank\" rel=\"noopener\">nih.gov<\/a><\/li>\n<li>Li, S. et al. “NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: a double-blind, randomized, placebo-controlled study.” Applied Physiology, Nutrition, and Metabolism, 2010. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21164548\/\" target=\"_blank\" rel=\"noopener\">nih.gov<\/a><\/li>\n<li>Hobden, M.R. et al. “Impact of dietary supplementation with resistant dextrin (NUTRIOSE\u00ae) on satiety, glycaemia, and related endpoints, in healthy adults.” European Journal of Nutrition, 2021. <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8572182\/\" target=\"_blank\" rel=\"noopener\">nih.gov<\/a><\/li>\n<li>Barber, C. et al. “Effect of Resistant Dextrin on Intestinal Gas Homeostasis and Microbiota.” Nutrients, 2022. <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9654059\/\" target=\"_blank\" rel=\"noopener\">nih.gov<\/a><\/li>\n<li>van den Heuvel, E.G.H.M. et al. “Short-term digestive tolerance of different doses of NUTRIOSE FB, a food dextrin, in adult men.” European Journal of Clinical Nutrition, 2004. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15220947\/\" target=\"_blank\" rel=\"noopener\">nih.gov<\/a><\/li>\n<li>Otsuka Pharmaceutical. “Indigestible dextrin.” Health and Illness Library. <a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\" target=\"_blank\" rel=\"noopener\">otsuka.co.jp<\/a><\/li>\n<li>Everyday Health. “Psyllium vs. Dextrin: Which Is the Better Fiber Supplement?” 2026. <a href=\"https:\/\/www.everydayhealth.com\/nutrients-supplements\/psyllium-vs-wheat-dextrin\/\" target=\"_blank\" rel=\"noopener\">everydayhealth.com<\/a><\/li>\n<li>EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). “Scientific Opinion on the substantiation of a health claim related to Nutriose\u00ae06 and a reduction of post-prandial glycaemic responses.” EFSA Journal, 2014. <a href=\"https:\/\/efsajournal.onlinelibrary.wiley.com\/doi\/10.2903\/j.efsa.2014.3839\" target=\"_blank\" rel=\"noopener\">wiley.com<\/a><\/li>\n<li>Health Canada. “List of Dietary Fibres Reviewed and Accepted by Health Canada’s Food Directorate.” <a href=\"https:\/\/www.canada.ca\/en\/health-canada\/services\/publications\/food-nutrition\/list-reviewed-accepted-dietary-fibres.html\" target=\"_blank\" rel=\"noopener\">canada.ca<\/a><\/li>\n<li>Business Research Insights. “Resistant Dextrin Market Report.” 2024 (accessed via Global Prebiotic Association compilation). <a href=\"https:\/\/www.businessresearchinsights.com\/market-reports\/resistant-dextrin-market-100208\" target=\"_blank\" rel=\"noopener\">businessresearchinsights.com<\/a><\/li>\n\n<\/ol>\n<\/div>\n<\/article>\n<\/div>\n\n<\/body><\/html>\n","protected":false},"featured_media":7997,"template":"","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"Resistant Dextrin Benefits: Evidence, Dosage and Uses","_seopress_titles_desc":"Learn what resistant dextrin does, which benefits are supported by evidence, and how to assess dosage, tolerance and sourcing.","_seopress_robots_index":""},"categories":[],"class_list":["post-7994","blogs","type-blogs","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.saigaoingredients.com\/es\/wp-json\/wp\/v2\/blogs\/7994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.saigaoingredients.com\/es\/wp-json\/wp\/v2\/blogs"}],"about":[{"href":"https:\/\/www.saigaoingredients.com\/es\/wp-json\/wp\/v2\/types\/blogs"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.saigaoingredients.com\/es\/wp-json\/wp\/v2\/media\/7997"}],"wp:attachment":[{"href":"https:\/\/www.saigaoingredients.com\/es\/wp-json\/wp\/v2\/media?parent=7994"}],"wp:term":[{"taxonomy":"categories","embeddable":true,"href":"https:\/\/www.saigaoingredients.com\/es\/wp-json\/wp\/v2\/categories?post=7994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

{"id":7994,"date":"2026-09-20T01:37:51","date_gmt":"2026-09-20T01:37:51","guid":{"rendered":"https:\/\/www.saigaoingredients.com\/?post_type=blogs&p=7994"},"modified":"2026-10-08T08:39:43","modified_gmt":"2026-10-08T08:39:43","slug":"resistant-dextrin","status":"publish","type":"blogs","link":"https:\/\/www.saigaoingredients.com\/es\/blogs\/resistant-dextrin\/","title":{"rendered":"Dextrina resistente: qu\u00e9 es, qu\u00e9 dicen las pruebas y si es buena para la salud"},"content":{"rendered":"\n\n\n\n\nResistant Dextrin: What It Is, What the Evidence Says, and Whether It’s Good for You<\/title>\n<\/head>\n<body>\n\n<div class=\"bd-post\">\n<style>\n@import url('https:\/\/fonts.googleapis.com\/css2?family=Inter:wght@500;600;700&display=swap');\n\n.bd-post {\n --prose-width: 744px;\n --gap-normal: 32px;\n --gap-section: 48px;\n --pad-compact: 16px;\n --pad-standard: 24px;\n --body-bg: #FFFFFF;\n --text-primary: #000000;\n --text-secondary: #666666;\n --text-accent: #3D7A28;\n --card-fill: #F6FCEA;\n --card-border: #5C9647;\n --inverse-bg: #232E34;\n --inverse-text-primary: #FFFFFF;\n --inverse-text-secondary: #A0B0A0;\n --inverse-text-accent: #9FE125;\n --accent: #9FE125;\n --btn-white: #FFFFFF;\n --btn-ink: #232E34;\n --refs-text: #6E6E6E;\n --refs-link: #2A76B4;\n font-family: \"Inter\", sans-serif;\n font-size: 16px;\n font-weight: 500;\n line-height: 1.5;\n color: var(--text-primary);\n background: var(--body-bg);\n padding: 40px;\n max-width: 100%;\n box-sizing: border-box;\n}\n.bd-post a { overflow-wrap: anywhere; word-break: break-word; }\n.bd-post p a, .bd-post li a, .bd-post blockquote a, .bd-post td a { color: var(--text-accent); text-decoration: underline; }\n.bd-post p, .bd-post li { overflow-wrap: break-word; }\n.bd-post .bd-post-article { max-width: var(--prose-width); margin: 0 auto; }\n\n\/* PROSE SPACING *\/\n.bd-post p { margin: 0 0 1em; }\n.bd-post h1 { font-family: \"Inter\", sans-serif; font-weight: 600; font-size: 50px; line-height: 1.2; color: var(--text-primary); margin: 0 0 16px; }\n.bd-post h2 { font-family: \"Inter\", sans-serif; font-weight: 600; font-size: 45px; line-height: 1.2; color: var(--text-primary); margin: 48px 0 16px; }\n.bd-post h3 { font-family: \"Inter\", sans-serif; font-weight: 600; font-size: 28px; line-height: 1.2; color: var(--text-primary); margin: 32px 0 12px; }\n.bd-post ul, .bd-post ol { margin: 0 0 1em; padding-left: 1.5em; }\n.bd-post li { margin-bottom: 0.5em; }\n.bd-post strong { font-weight: 700; }\n\n\/* box-sizing catch-all only *\/\n.bd-post [class*=\"bp-\"] { box-sizing: border-box; }\n.bd-post [class*=\"rich-\"] { box-sizing: border-box; }\n\n\/* BP outer margins \u2014 per-class explicit *\/\n.bd-post .bd-post-article > .bp-1-verdict { margin: var(--gap-normal) 0; }\n.bd-post .bd-post-article > .bp-2-juris { margin: var(--gap-normal) 0; }\n.bd-post .bd-post-article > .bp-cta-end { margin: var(--gap-section) 0; }\n.bd-post .bd-post-article > .table-wrapper { margin: var(--gap-normal) 0; }\n.bd-post .bd-post-article > .rich-callout { margin: var(--gap-normal) 0; }\n.bd-post .bd-post-article > .rich-checklist { margin: var(--gap-normal) 0; }\n\n\/* ---------- BP-1 verdict signature card ---------- *\/\n.bd-post .bp-1-verdict {\n background: var(--card-fill);\n border: 1.5px solid var(--card-border);\n border-radius: 20px 0 20px 0;\n box-shadow: 5px 5px 0 var(--accent);\n padding: var(--pad-standard);\n}\n.bd-post .bp-1-eyebrow { font-size: 13px; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--text-accent); margin: 0 0 8px; }\n.bd-post .bp-1-title { font-size: 24px; font-weight: 600; line-height: 1.25; color: var(--text-primary); margin: 0 0 12px; }\n.bd-post .bp-1-ticon { display: inline-flex; vertical-align: -0.2em; margin-right: 10px; }\n.bd-post .bp-1-ticon svg { width: 24px; height: 24px; }\n.bd-post .bp-1-body { font-size: 16px; line-height: 1.6; color: var(--text-primary); margin: 0 0 16px; }\n.bd-post .bp-1-chips { display: flex; flex-wrap: wrap; gap: 10px; margin: 0 0 16px; }\n.bd-post .bp-1-chip {\n display: inline-flex; align-items: center; gap: 6px;\n background: var(--body-bg);\n border: 1px solid var(--card-border);\n border-radius: 999px;\n padding: 6px 12px;\n font-size: 12px; font-weight: 600; letter-spacing: 0.06em; text-transform: uppercase;\n color: var(--text-accent);\n}\n.bd-post .bp-1-chip svg { width: 14px; height: 14px; }\n.bd-post .bp-1-source { font-size: 12px; line-height: 1.5; color: var(--text-secondary); border-top: 1px solid var(--card-border); padding: var(--pad-compact) 0 0; }\n\n\/* ---------- BP-2 jurisdictions grid ---------- *\/\n.bd-post .bp-2-juris {\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-radius: 20px;\n padding: var(--pad-standard);\n}\n.bd-post .bp-2-jtitle { font-size: 20px; font-weight: 600; line-height: 1.25; color: var(--text-primary); margin: 0 0 16px; }\n.bd-post .bp-2-ticon { display: inline-flex; vertical-align: -0.2em; margin-right: 10px; }\n.bd-post .bp-2-ticon svg { width: 22px; height: 22px; }\n.bd-post .bp-2-grid { display: grid; grid-template-columns: repeat(4, 1fr); gap: 16px; margin: 0 0 16px; }\n.bd-post .bp-2-cell {\n background: var(--body-bg);\n border: 1px solid var(--card-border);\n border-radius: 10px;\n padding: 16px;\n}\n.bd-post .bp-2-region { display: block; font-size: 13px; font-weight: 600; letter-spacing: 0.06em; text-transform: uppercase; color: var(--text-accent); margin: 0 0 8px; }\n.bd-post .bp-2-text { font-size: 14px; line-height: 1.6; color: var(--text-primary); }\n.bd-post .bp-2-source { font-size: 12px; line-height: 1.5; color: var(--text-secondary); border-top: 1px solid var(--card-border); padding: var(--pad-compact) 0 0; }\n\n\/* ---------- CTA end ---------- *\/\n.bd-post .bp-cta-end {\n background: var(--inverse-bg);\n border-radius: 20px;\n padding: var(--pad-standard);\n color: var(--inverse-text-primary);\n display: flex;\n flex-direction: column;\n align-items: center;\n text-align: center;\n}\n.bd-post .bp-cta-end-title { font-size: 26px; font-weight: 600; line-height: 1.25; color: var(--inverse-text-primary); margin: 0 0 12px; }\n.bd-post .bp-cta-end-ticon { display: inline-flex; vertical-align: -0.2em; margin-right: 10px; }\n.bd-post .bp-cta-end-ticon svg { width: 22px; height: 22px; color: var(--inverse-text-accent); }\n.bd-post .bp-cta-end-sub { max-width: 680px; font-size: 15px; line-height: 1.6; color: var(--inverse-text-secondary); margin: 0 0 20px; }\n.bd-post .bp-cta-end-btn {\n display: inline-flex; align-items: center; gap: 8px;\n background: var(--accent);\n color: var(--btn-ink);\n border-radius: 999px;\n padding: 15px 28px;\n font-family: \"Inter\", sans-serif;\n font-size: 16px; font-weight: 600; line-height: 1.2;\n text-decoration: none;\n transition: transform .2s ease-out, background .2s ease-out, color .2s ease-out;\n}\n.bd-post .bp-cta-end-btn:hover { background: var(--btn-white); color: var(--btn-ink); transform: translateY(-2px); }\n.bd-post .bp-cta-end-btn svg { width: 18px; height: 18px; }\n\n\/* ---------- rich: tables ---------- *\/\n.bd-post .table-wrapper { overflow-x: auto; }\n.bd-post .rich-table { border-collapse: collapse; width: 100%; }\n.bd-post .rich-table th {\n text-align: left; vertical-align: top;\n font-size: 14px; font-weight: 600; line-height: 1.4; color: var(--text-primary);\n background: transparent;\n border-bottom: 2px solid var(--card-border);\n padding: 10px 12px;\n}\n.bd-post .rich-table td {\n font-size: 15px; line-height: 1.5; color: var(--text-primary);\n border-bottom: 1px solid var(--card-border);\n padding: 12px;\n vertical-align: top;\n}\n.bd-post .rich-table td:first-child { font-weight: 600; }\n.bd-post .rich-source { font-size: 12px; line-height: 1.5; color: var(--text-secondary); border-top: 1px solid var(--card-border); padding: var(--pad-compact) 0 0; margin-top: 2px; }\n\n\/* ---------- rich: callout (info) ---------- *\/\n.bd-post .rich-callout {\n display: flex; align-items: flex-start; gap: 16px;\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-left: 3px solid var(--text-accent);\n border-radius: 10px;\n padding: var(--pad-compact);\n}\n.bd-post .rich-callout-icon { flex: 0 0 auto; display: inline-flex; }\n.bd-post .rich-callout-icon svg { width: 22px; height: 22px; color: var(--text-accent); }\n.bd-post .rich-callout-body { flex: 1 1 auto; min-width: 0; }\n.bd-post .rich-callout-text { font-size: 15px; line-height: 1.6; color: var(--text-primary); }\n.bd-post .rich-callout-source { font-size: 12px; line-height: 1.5; color: var(--text-secondary); border-top: 1px solid var(--card-border); padding: var(--pad-compact) 0 0; margin-top: 12px; }\n\n\/* ---------- rich: checklist ---------- *\/\n.bd-post .rich-checklist {\n background: var(--card-fill);\n border: 1px solid var(--card-border);\n border-radius: 20px;\n padding: var(--pad-standard);\n}\n.bd-post .rich-checklist-title { font-size: 20px; font-weight: 600; line-height: 1.25; color: var(--text-primary); margin: 0 0 16px; }\n.bd-post .rich-checklist-ticon { display: inline-flex; vertical-align: -0.2em; margin-right: 10px; }\n.bd-post .rich-checklist-ticon svg { width: 22px; height: 22px; color: var(--text-accent); }\n.bd-post .rich-checklist-grid { display: grid; grid-template-columns: repeat(2, 1fr); gap: 24px; margin: 0 0 16px; }\n.bd-post .rich-checklist-head { font-size: 17px; font-weight: 600; color: var(--text-primary); margin: 0 0 10px; }\n.bd-post .rich-checklist-item { display: flex; align-items: flex-start; gap: 8px; margin: 0 0 8px; }\n.bd-post .rich-checklist-item svg { flex: 0 0 auto; width: 16px; height: 16px; color: var(--text-accent); margin-top: 3px; }\n.bd-post .rich-checklist-item div { font-size: 15px; line-height: 1.6; color: var(--text-primary); }\n.bd-post .rich-checklist-source { font-size: 12px; line-height: 1.5; color: var(--text-secondary); border-top: 1px solid var(--card-border); padding: var(--pad-compact) 0 0; }\n\n\/* ---------- references ---------- *\/\n.bd-post .bd-refs { margin: var(--gap-section) 0 0; border-top: 1px solid var(--card-border); font-weight: 400; }\n.bd-post .bd-refs h2 { font-size: 28px; margin: 48px 0 16px; }\n.bd-post .bd-refs ol { margin: 0; padding-left: 1.5em; }\n.bd-post .bd-refs li { font-size: 14px; line-height: 1.5; color: var(--text-secondary); overflow-wrap: anywhere; word-break: break-word; }\n\n\/* ---------- motion ---------- *\/\n@media (prefers-reduced-motion: no-preference) {\n @supports (animation-timeline: view()) {\n .bd-post .bd-reveal { animation: bd-fade-in linear both; animation-timeline: view(); animation-range: entry 0% entry 35%; }\n @keyframes bd-fade-in { from { opacity: 0; } to { opacity: 1; } }\n }\n .bd-post h2 { transition: color .2s ease-out, transform .2s ease-out; transform-origin: left; }\n .bd-post h2:hover { color: var(--text-accent); transform: scale(1.01); }\n .bd-post .bp-cta-end-btn { transition: transform .2s ease-out, background .2s ease-out, color .2s ease-out; }\n .bd-post .bd-post-article a { transition: color .2s ease-out; }\n}\n\n\/* ---------- mobile ---------- *\/\n@media (max-width: 768px) {\n .bd-post { padding: 16px; }\n .bd-post h1 { font-size: 32px; }\n .bd-post h2 { font-size: 30px; margin-top: 32px; }\n .bd-post h3 { font-size: 20px; margin-top: 24px; }\n .bd-post .bd-refs h2 { font-size: 22px; }\n .bd-post .bp-1-title { font-size: 20px; }\n .bd-post .bp-1-title svg { width: 20px; height: 20px; }\n .bd-post .bp-cta-end-title { font-size: 20px; }\n .bd-post .bp-cta-end-ticon svg { width: 18px; height: 18px; }\n .bd-post .bp-2-grid { grid-template-columns: repeat(2, 1fr); }\n .bd-post .rich-checklist-grid { grid-template-columns: 1fr; }\n \/* tables stack *\/\n .bd-post .rich-table thead { display: none; }\n .bd-post .rich-table tbody tr { display: block; border: 1px solid var(--card-border); border-radius: 8px; overflow: hidden; margin: 0 0 12px; }\n .bd-post .rich-table td { display: block; width: 100%; border-bottom: 1px solid var(--card-border); padding: 10px 15px; box-sizing: border-box; }\n .bd-post .rich-table td:last-child { border-bottom: 0; }\n .bd-post .rich-table td::before {\n content: attr(data-label);\n display: block;\n font-size: 13px; font-weight: 700; letter-spacing: .04em; text-transform: uppercase;\n color: var(--text-secondary);\n margin: 0 0 4px;\n }\n .bd-post .rich-table td:first-child { background: var(--card-fill); }\n .bd-post .rich-table td:first-child::before { content: none; }\n}\n\/* NO dark-mode block: light-only deployment *\/\n<\/style>\n<article class=\"bd-post-article\">\n\n<p>You have probably met resistant dextrin without noticing. It appears on labels as soluble corn fiber, soluble tapioca fiber, resistant maltodextrin, or, in Asia-Pacific markets, indigestible dextrin. Because the word “dextrin” sits in several of those names, a fair number of shoppers quietly wonder whether this is just maltodextrin wearing a disguise. It is not, and the difference matters. But the more interesting question is the one the marketing rarely answers precisely: which of the claimed benefits are actually proven, at what dose, and for whom. This article walks the ingredient through the body, then grades the evidence claim by claim. That way you can decide what resistant dextrin can honestly do for you, or for a product you are developing.<\/p>\n\n<h2>What Resistant Dextrin Is, and Where It Sits in the Dextrin Family<\/h2>\n<p>Start with the family tree, because the confusion is a naming problem before it is a nutrition problem. All of these ingredients begin as starch. Heat that starch with a food-grade acid or enzyme and it breaks into shorter glucose chains called dextrins. Keep going and you get maltodextrin, the fully digestible, high-glycemic filler that snack critics love to hate. Resistant dextrin takes the process one step further. The chains are re-linked with new bond types, including \u03b2-1,6 and \u03b2-1,2 bonds, that human small-intestinal enzymes cannot easily cut (<a href=\"https:\/\/prebioticassociation.org\/prebiotic-type-spotlight-resistant-dextrin\/\">Global Prebiotic Association<\/a>, 2024). Same feedstock, opposite behavior.<\/p>\n<p>Resistant starch, a name that appears in the same conversations, is a different ingredient entirely: it escapes digestion through physical structure rather than chemical re-linking. Similar gut outcome, different molecule.<\/p>\n<p>Once you know the family, the alias map makes sense. “Resistant maltodextrin” and “indigestible dextrin” describe the same ingredient class. The latter term dominates in Japan, where it is an approved functional ingredient in “foods for specified health use” (<a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\">Otsuka Pharmaceutical<\/a>). “Soluble corn fiber” and “soluble tapioca fiber” are the US label names, referencing the starch source.<\/p>\n<p>What the body does with it explains why it counts as fiber at all. Roughly 15% is digested in the small intestine. About 75% reaches the colon and ferments slowly there. The remaining 10% passes out (<a href=\"https:\/\/prebioticassociation.org\/prebiotic-type-spotlight-resistant-dextrin\/\">Global Prebiotic Association<\/a>, 2024, citing Shamasbi et al. 2019). That colonic journey, not the glucose backbone, is where every claimed benefit begins.<\/p>\n\n<div class=\"table-wrapper bd-reveal\">\n<table class=\"rich-table\">\n<thead><tr><th>Name<\/th><th>What it is<\/th><th>Digestive behavior<\/th><th>Where you meet it<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>Dextrin<\/td><td data-label=\"What it is\">Short glucose chains from heated starch<\/td><td data-label=\"Digestive behavior\">Largely digestible<\/td><td data-label=\"Where you meet it\">Glues, browning on baked surfaces<\/td><\/tr>\n<tr><td>Maltodextrin<\/td><td data-label=\"What it is\">Enzymatically converted starch, graded by DE value<\/td><td data-label=\"Digestive behavior\">Fully digestible, high glycemic impact<\/td><td data-label=\"Where you meet it\">Bulking and texture in processed foods<\/td><\/tr>\n<tr><td>Resistant dextrin<\/td><td data-label=\"What it is\">Re-polymerized starch fiber with new bond types<\/td><td data-label=\"Digestive behavior\">About 15% digested; 75% colonic fermentation; 10% excreted<\/td><td data-label=\"Where you meet it\">Fiber-fortified bars, drinks, keto products<\/td><\/tr>\n<tr><td>Resistant starch<\/td><td data-label=\"What it is\">Physically protected starch granules<\/td><td data-label=\"Digestive behavior\">Escapes digestion structurally<\/td><td data-label=\"Where you meet it\">Cooled potatoes, green bananas, RS2\/RS3 ingredients<\/td><\/tr>\n<\/tbody>\n<\/table>\n<div class=\"rich-source\">Source: Global Prebiotic Association (2024); Otsuka Pharmaceutical; Wikipedia (dextrin overview)<\/div>\n<\/div>\n\n<h2>The Journey: What Your Body Does With Resistant Dextrin<\/h2>\n<p>The colonic 75% is not passive transit. It is fuel, and the list of downstream effects follows directly from how that fuel gets used.<\/p>\n<h3>In the colon: fermentation, short-chain fatty acids, and that gassy first week<\/h3>\n<p>Gut bacteria ferment resistant dextrin into short-chain fatty acids, and the fermentation is selective. Studies report increases in beneficial genera such as Bacteroides and Parabacteroides alongside reductions in Clostridium perfringens (<a href=\"https:\/\/prebioticassociation.org\/prebiotic-type-spotlight-resistant-dextrin\/\">Global Prebiotic Association<\/a>, 2024, citing Thirion et al. 2022). Fermentation produces gas as a byproduct, which is why fiber newcomers often feel bloated in the first days. The same controlled trial tracked this adaptation. The microbiota shifts toward lower-gas fermentation pathways over time, so the early discomfort typically recedes (<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9654059\/\">Barber et al.<\/a>, 2022).<\/p>\n\n<div class=\"rich-callout bd-reveal\">\n<span class=\"rich-callout-icon\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"M12 16v-4\"\/><path d=\"M12 8h.01\"\/><\/svg><\/span>\n<div class=\"rich-callout-body\">\n<div class=\"rich-callout-text\">Expect an adjustment window. Gas and bloating in the first one to two weeks are a normal fermentation response for most people, not a sign the ingredient is wrong for you. Ramp up the dose gradually and they usually settle.<\/div>\n<div class=\"rich-callout-source\">Source: Barber et al. 2022 (Nutrients, PMC9654059); r\/Microbiome community reports on fiber adaptation<\/div>\n<\/div>\n<\/div>\n<h3>Blood sugar: a flatter curve by slowing maltose digestion<\/h3>\n<p>Resistant dextrin does not block glucose absorption. Its documented mechanism is narrower and more elegant: it slows the digestion of maltose, the double sugar that starch breaks into. Taken with a meal, that flattens the post-meal glucose rise. Japanese trials summarized by Otsuka found no effect on glucose or fructose itself. They did find significant suppression of the blood sugar rise when five grams were taken with a noodle meal (<a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\">Otsuka Pharmaceutical<\/a>). In people with type 2 diabetes, longer supplementation has translated into measurable insulin-resistance improvements, a point the next section grades.<\/p>\n<h3>Blood fats and visceral fat<\/h3>\n<p>The same slowing effect extends to fat. Taken with meals, resistant dextrin blunts the post-meal triglyceride rise. In a 12-week trial, 36 overweight men drank tea with nine grams of indigestible dextrin daily. Compared with the plain-tea group, they showed significant decreases in visceral fat area and triglycerides (<a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\">Otsuka Pharmaceutical<\/a>, citing Obesity Research, 2007).<\/p>\n\n <img decoding=\"async\" src=\"https:\/\/www.saigaoingredients.com\/wp-content\/uploads\/2026\/09\/Resistant-Dextrin-1.webp\" style=\"width: 512px; height: 384px; max-width: 100%; object-fit: cover; border-radius: 12px; margin: 30px auto; display: block; box-shadow: 10px 10px 60px 0px rgba(210, 221, 224, 0.35); transition: all 0.3s ease; cursor: pointer;\" onmouseover=\"this.style.transform='translateY(-5px) scale(1.03)'; this.style.boxShadow='15px 25px 80px 0px rgba(210, 221, 224, 0.45)'\" onmouseout=\"this.style.transform='translateY(0) scale(1)'; this.style.boxShadow='10px 10px 60px 0px rgba(210, 221, 224, 0.35)'\"> \n\n<h3>Fullness and minerals<\/h3>\n<p>Two quieter effects round out the journey. On satiety, a controlled study in healthy adults found resistant dextrin modified fullness and glycemic responses, though the authors were explicit that long-term weight effects need more study (<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8572182\/\">Hobden et al.<\/a>, 2021). Separate work found breakfast intake blunted the hunger hormone ghrelin’s rise before lunch. On minerals, fermentation acids appear to improve uptake of calcium, magnesium, iron, and zinc. In one trial, young women with low serum iron took 15 grams daily for four weeks, and their iron status improved (<a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\">Otsuka Pharmaceutical<\/a>).<\/p>\n\n<h2>Is Resistant Dextrin Good for You? Grading the Evidence<\/h2>\n<p>Here is where the sources diverge. Industry summaries list a dozen benefits; medical consumer sites call the evidence inconclusive. Both camps are looking at the same literature. The difference is grading: the benefits are not equally proven, and once you sort them into tiers, the contradiction dissolves.<\/p>\n<h3>What is well proven<\/h3>\n<p>Two randomized controlled trials anchor the strong tier. In women with type 2 diabetes, ten grams of resistant dextrin daily for eight weeks significantly improved insulin resistance and inflammation markers versus placebo (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27028002\/\">Aliasgharzadeh et al.<\/a>, 2015). In overweight men, supplementation improved insulin resistance and determinants of metabolic syndrome and was well tolerated (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21164548\/\">Li et al.<\/a>, 2010).<\/p>\n<p>Safety runs deep, too. A 16-week study took ten grams three times daily and found no adverse physiological changes. Serum protein and minerals, including calcium, magnesium, and iron, stayed stable (<a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\">Otsuka Pharmaceutical<\/a>, citing the Japanese Journal of Clinical Nutrition, 1993).<\/p>\n<h3>What is promising but not settled<\/h3>\n<p>Satiety and weight sit here. The 2021 healthy-adult trial found fullness responses modified but flagged the need for long-term data (<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8572182\/\">Hobden et al.<\/a>, 2021). An earlier trial found no appetite effect at all, a split that medical reviewers read honestly as unsettled (<a href=\"https:\/\/www.everydayhealth.com\/nutrients-supplements\/psyllium-vs-wheat-dextrin\/\">Everyday Health<\/a>, 2026). Blood-lipid improvement likewise remains inconclusive in review articles. Note a subtlety much of the skeptical coverage misses: the cautious verdicts often concern wheat dextrin, the common supplement fiber, not resistant dextrin specifically. Related, but a different molecule with its own thinner evidence file.<\/p>\n<h3>How much: the dose windows<\/h3>\n<p>Dose is where most real-world disappointment lives, because benefit thresholds and comfort ceilings are different numbers. For planning purposes, the working dose map looks like this. Gut-microbiota effects show dose response from 5 to 20 g\/day (<a href=\"https:\/\/prebioticassociation.org\/prebiotic-type-spotlight-resistant-dextrin\/\">Global Prebiotic Association<\/a>, 2024, citing Thirion et al. 2022). Satiety studies cluster at 8 to 14 g\/day, and the metabolic trials used 10 g\/day. Short-term tolerance extends to 50 g\/day in divided doses (Marteau et al. 2011, via the same review). Food-formulation studies have accommodated 20 to 25% of product composition without undesirable effects (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15220947\/\">van den Heuvel et al.<\/a>, 2004).<\/p>\n\n<div class=\"bp-1-verdict bd-reveal\">\n<div class=\"bp-1-eyebrow\">The evidence, graded<\/div>\n<div class=\"bp-1-title\"><span class=\"bp-1-ticon\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><polygon points=\"12 2 2 7 12 12 22 7 12 2\"\/><polyline points=\"2 17 12 22 22 17\"\/><polyline points=\"2 12 12 17 22 12\"\/><\/svg><\/span>Three Evidence Tiers, One Ingredients List<\/div>\n<div class=\"bp-1-body\">Its benefits are real but not equally proven. Insulin-resistance improvement at 10 g\/day in type 2 diabetes is randomized-trial evidence; “lowers blood lipids” is still graded inconclusive.<\/div>\n<div class=\"bp-1-chips\">\n<span class=\"bp-1-chip\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg>Proven<\/span>\n<span class=\"bp-1-chip\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><polyline points=\"22 7 13.5 15.5 8.5 10.5 2 17\"\/><polyline points=\"16 7 22 7 22 13\"\/><\/svg>Promising<\/span>\n<span class=\"bp-1-chip\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"M9.09 9a3 3 0 0 1 5.83 1c0 2-3 3-3 3\"\/><path d=\"M12 17h.01\"\/><\/svg>Inconclusive<\/span>\n<\/div>\n<div class=\"bp-1-source\">Source: Aliasgharzadeh 2015 (PMID 27028002); Everyday Health evidence review 2026<\/div>\n<\/div>\n<p>Placed side by side, the outcomes grade cleanly. The table below is the one worth keeping: it is the difference between a claim that survives scrutiny and one that quietly overpromises.<\/p>\n\n<div class=\"table-wrapper bd-reveal\">\n<table class=\"rich-table\">\n<thead><tr><th>Outcome<\/th><th>Evidence tier<\/th><th>Key population and dose<\/th><th>When it falls short or needs care<\/th><\/tr><\/thead>\n<tbody>\n<tr><td>Insulin resistance and inflammation (type 2 diabetes)<\/td><td data-label=\"Evidence tier\">Proven: randomized controlled trials<\/td><td data-label=\"Key population and dose\">Women with T2D, 10 g\/day for 8 weeks<\/td><td data-label=\"When it falls short or needs care\">Trial population was T2D women; extrapolate cautiously<\/td><\/tr>\n<tr><td>Metabolic syndrome markers<\/td><td data-label=\"Evidence tier\">Proven: randomized controlled trial<\/td><td data-label=\"Key population and dose\">Overweight men, daily supplementation<\/td><td data-label=\"When it falls short or needs care\">Well tolerated in trial; longer-term data thinner<\/td><\/tr>\n<tr><td>Post-meal blood sugar<\/td><td data-label=\"Evidence tier\">Proven mechanism, human confirmation<\/td><td data-label=\"Key population and dose\">Taken with maltose\/starch meals, 5 g and up<\/td><td data-label=\"When it falls short or needs care\">Does not block glucose itself; effects depend on the meal<\/td><\/tr>\n<tr><td>Visceral fat and triglycerides<\/td><td data-label=\"Evidence tier\">Promising<\/td><td data-label=\"Key population and dose\">Overweight men, 9 g\/day for 12 weeks<\/td><td data-label=\"When it falls short or needs care\">Single trial; grade as supportive, not settled<\/td><\/tr>\n<tr><td>Satiety and weight management<\/td><td data-label=\"Evidence tier\">Promising but split<\/td><td data-label=\"Key population and dose\">Healthy adults; doses from 8 to 14 g\/day<\/td><td data-label=\"When it falls short or needs care\">One trial positive, one null; long-term weight data lacking<\/td><\/tr>\n<tr><td>Gut microbiota and regularity<\/td><td data-label=\"Evidence tier\">Proven mechanism, doses mapped<\/td><td data-label=\"Key population and dose\">5 to 20 g\/day shows dose response<\/td><td data-label=\"When it falls short or needs care\">First 1 to 2 weeks of gas are adaptation, not failure<\/td><\/tr>\n<tr><td>Mineral absorption<\/td><td data-label=\"Evidence tier\">Early stage<\/td><td data-label=\"Key population and dose\">Animal data plus one 15 g\/day human trial<\/td><td data-label=\"When it falls short or needs care\">Human evidence base is small<\/td><\/tr>\n<tr><td>General blood-lipid lowering<\/td><td data-label=\"Evidence tier\">Inconclusive<\/td><td data-label=\"Key population and dose\">Reviews of mixed dextrin evidence<\/td><td data-label=\"When it falls short or needs care\">Do not put this on a product claim yet<\/td><\/tr>\n<\/tbody>\n<\/table>\n<div class=\"rich-source\">Source: Aliasgharzadeh 2015 (PMID 27028002); Li 2010 (PMID 21164548); Hobden 2021; Barber 2022; Otsuka; Everyday Health 2026<\/div>\n<\/div>\n<p>The practical rule every trial repeats: start low, ramp up over a couple of weeks, and let the microbiota adapt.<\/p>\n<h3>Who should be careful<\/h3>\n<p>Three groups deserve explicit notes. People with celiac disease or gluten sensitivity must check the starch source before assuming any dextrin is safe, because wheat-derived dextrin can carry gluten. Corn- and tapioca-based resistant dextrin is naturally gluten-free, so source documentation settles the question (<a href=\"https:\/\/www.everydayhealth.com\/nutrients-supplements\/psyllium-vs-wheat-dextrin\/\">Everyday Health<\/a>, 2026). People with inflammatory bowel disease or a history of intestinal blockages should talk to a clinician before adding any fermentable fiber. And for pregnant women and young children, the trial base is thin; absence of evidence is not evidence of harm, but it is also not a green light.<\/p>\n<p>So, is it good for you? For most people, at realistic doses, the honest answer is yes with precision. The metabolic and gut benefits are genuinely documented. The size of the promise should match the tier of evidence, and the dose should match the goal.<\/p>\n\n<h2>From Evidence to Product: Rules, Sources, and Forms<\/h2>\n<p>If you are building with this ingredient rather than eating it, the same evidence tiers become the boundary of what you can honestly claim. Three practical axes decide the fit.<\/p>\n<p>The regulatory footing is established across major markets, with different mechanics in each.<\/p>\n\n<div class=\"bp-2-juris bd-reveal\">\n<div class=\"bp-2-jtitle\"><span class=\"bp-2-ticon\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><circle cx=\"12\" cy=\"12\" r=\"10\"\/><path d=\"M12 2a14.5 14.5 0 0 0 0 20 14.5 14.5 0 0 0 0-20\"\/><path d=\"M2 12h20\"\/><\/svg><\/span>One Ingredient, Four Regulatory Footings<\/div>\n<div class=\"bp-2-grid\">\n<div class=\"bp-2-cell\"><span class=\"bp-2-region\">United States<\/span><div class=\"bp-2-text\">Meets the FDA’s dietary fiber definition; widely supplied under GRAS notifications.<\/div><\/div>\n<div class=\"bp-2-cell\"><span class=\"bp-2-region\">European Union<\/span><div class=\"bp-2-text\">EFSA’s 2014 scientific opinion found the ingredient sufficiently characterized, with an assessed pathway for post-meal glycemic claims.<\/div><\/div>\n<div class=\"bp-2-cell\"><span class=\"bp-2-region\">Canada<\/span><div class=\"bp-2-text\">Accepted on Health Canada’s list of reviewed dietary fibres as a novel fibre.<\/div><\/div>\n<div class=\"bp-2-cell\"><span class=\"bp-2-region\">Japan<\/span><div class=\"bp-2-text\">Approved as a functional ingredient in “foods for specified health use” (FOSHU).<\/div><\/div>\n<\/div>\n<div class=\"bp-2-source\">Source: Global Prebiotic Association 2024; EFSA Journal 2014;12(10):3839; Health Canada fibre list<\/div>\n<\/div>\n<p>Formulation-wise, the starch source is a specification, not a detail. Wheat-derived material needs gluten handling for sensitive markets; corn- and tapioca-based grades are naturally gluten-free, which is why most global supply runs on those two sources. Grade matters next. A typical 90% corn-based resistant dextrin powder specification publishes total dietary fiber at \u226590.0% on a dry basis. 70% grades trade fiber density for cost in applications where the claim does not need to be maximal (<a href=\"https:\/\/www.saigaoingredients.com\/products\/90-corn-resistant-dextrin-powder-soluble-corn-fiber-powder\/\">example 90% grade specification<\/a>). Form follows the application. Powders meter and store well for bars and blends; syrups bind and sweeten in one stroke for bars and beverages. Low viscosity, a near-transparent solution, and heat and acid stability are what make the ingredient beverage-friendly (<a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\">Otsuka Pharmaceutical<\/a>). The market context supports the build-out. Analysts sized the global resistant dextrin market at $382.9 million in 2022, projecting $752.64 million by 2031, a 7.8% CAGR (Business Research Insights, as compiled by the <a href=\"https:\/\/prebioticassociation.org\/prebiotic-type-spotlight-resistant-dextrin\/\">Global Prebiotic Association<\/a>).<\/p>\n\n<h2>What This Means for Your Product Program<\/h2>\n<p>Everything above compresses into two operating positions, depending on which side of the transaction you sit on.<\/p>\n<p>If you are developing a functional food, beverage, or supplement: build the product story on the proven tier. Insulin-resistance and metabolic-syndrome outcomes, gut-microbiota effects, and meal-context blood sugar support are all defensible with citations. Treat weight management and lipid claims as direction, not promise, until the literature firms up. And invest in the education most brands skip. Telling consumers about the one-to-two-week adaptation window, and explaining the dextrin family in your own packaging copy, pre-empts both the “maltodextrin in disguise” suspicion and the bloated-week-one one-star review.<\/p>\n<p>If you are a distributor or importer stocking the category: growth projections justify the shelf space, but supplier quality decides whether it stays. Three questions separate professional suppliers from the rest, and they map directly to this article. One: what fiber percentage, on what grade and dry-basis basis, backed by which documentation. Two: what starch source, with gluten status stated. Three: what batch-to-batch consistency data and certification file comes with the shipment.<\/p>\n\n<div class=\"rich-checklist bd-reveal\">\n<div class=\"rich-checklist-title\"><span class=\"rich-checklist-ticon\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"m3 17 2 2 4-4\"\/><path d=\"m3 7 2 2 4-4\"\/><path d=\"M13 6h8\"\/><path d=\"M13 12h8\"\/><path d=\"M13 18h8\"\/><\/svg><\/span>Your Operating Checklists<\/div>\n<div class=\"rich-checklist-grid\">\n<div>\n<div class=\"rich-checklist-head\">For brand and product teams<\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Anchor claims to proven-tier outcomes (insulin resistance, metabolic syndrome markers, microbiota, meal-context glycemia)<\/div><\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Keep weight and lipid messaging at “emerging evidence” strength<\/div><\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Put the adaptation window in onboarding copy and FAQs<\/div><\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Name the ingredient’s family and aliases on pack to defuse the maltodextrin confusion<\/div><\/div>\n<\/div>\n<div>\n<div class=\"rich-checklist-head\">For distributors and importers<\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Require fiber content with grade and dry-basis basis in writing<\/div><\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Confirm starch source and gluten-free status per lot specification<\/div><\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Demand batch-consistency data and certification documentation (non-GMO, Kosher, Halal as applicable)<\/div><\/div>\n<div class=\"rich-checklist-item\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M20 6 9 17l-5-5\"\/><\/svg><div>Use the three-tier evidence framing when training downstream sales teams<\/div><\/div>\n<\/div>\n<\/div>\n<div class=\"rich-checklist-source\">Source: Evidence tiers per this article’s Sections 3-4; supplier documentation practice per published specification sheets<\/div>\n<\/div>\n\n<div class=\"bp-cta-end bd-reveal\">\n<div class=\"bp-cta-end-title\"><span class=\"bp-cta-end-ticon\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M5 12h14\"\/><path d=\"m12 5 7 7-7 7\"\/><\/svg><\/span>Source Resistant Dextrin With the Paperwork to Back It<\/div>\n<div class=\"bp-cta-end-sub\">SAIGAO supplies corn- and tapioca-based resistant dextrin as powder or syrup, in 70% and 90% grades. Ask for the specification sheet, the method note behind the fiber number, and batch-consistency data, with free samples within limits and replies to international inquiries inside 12 hours.<\/div>\n<a class=\"bp-cta-end-btn\" href=\"https:\/\/www.saigaoingredients.com\/contact\/\" target=\"_self\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\" stroke-linecap=\"round\" stroke-linejoin=\"round\"><path d=\"M5 12h14\"\/><path d=\"m12 5 7 7-7 7\"\/><\/svg>Request Specs & Samples<\/a>\n<\/div>\n\n<div class=\"bd-refs\">\n<h2>References<\/h2>\n<ol>\n<li>Global Prebiotic Association. “Prebiotic Type Spotlight: Resistant Dextrin.” 2024. <a href=\"https:\/\/prebioticassociation.org\/prebiotic-type-spotlight-resistant-dextrin\/\" target=\"_blank\" rel=\"noopener\">prebioticassociation.org<\/a><\/li>\n<li>Aliasgharzadeh, A. et al. “Resistant dextrin, as a prebiotic, improves insulin resistance and inflammation in women with type 2 diabetes: a randomised controlled clinical trial.” British Journal of Nutrition, 2015. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27028002\/\" target=\"_blank\" rel=\"noopener\">nih.gov<\/a><\/li>\n<li>Li, S. et al. “NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: a double-blind, randomized, placebo-controlled study.” Applied Physiology, Nutrition, and Metabolism, 2010. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21164548\/\" target=\"_blank\" rel=\"noopener\">nih.gov<\/a><\/li>\n<li>Hobden, M.R. et al. “Impact of dietary supplementation with resistant dextrin (NUTRIOSE\u00ae) on satiety, glycaemia, and related endpoints, in healthy adults.” European Journal of Nutrition, 2021. <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8572182\/\" target=\"_blank\" rel=\"noopener\">nih.gov<\/a><\/li>\n<li>Barber, C. et al. “Effect of Resistant Dextrin on Intestinal Gas Homeostasis and Microbiota.” Nutrients, 2022. <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9654059\/\" target=\"_blank\" rel=\"noopener\">nih.gov<\/a><\/li>\n<li>van den Heuvel, E.G.H.M. et al. “Short-term digestive tolerance of different doses of NUTRIOSE FB, a food dextrin, in adult men.” European Journal of Clinical Nutrition, 2004. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15220947\/\" target=\"_blank\" rel=\"noopener\">nih.gov<\/a><\/li>\n<li>Otsuka Pharmaceutical. “Indigestible dextrin.” Health and Illness Library. <a href=\"https:\/\/www.otsuka.co.jp\/en\/health-and-illness\/fiber\/about\/type\/dextrin\/\" target=\"_blank\" rel=\"noopener\">otsuka.co.jp<\/a><\/li>\n<li>Everyday Health. “Psyllium vs. Dextrin: Which Is the Better Fiber Supplement?” 2026. <a href=\"https:\/\/www.everydayhealth.com\/nutrients-supplements\/psyllium-vs-wheat-dextrin\/\" target=\"_blank\" rel=\"noopener\">everydayhealth.com<\/a><\/li>\n<li>EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). “Scientific Opinion on the substantiation of a health claim related to Nutriose\u00ae06 and a reduction of post-prandial glycaemic responses.” EFSA Journal, 2014. <a href=\"https:\/\/efsajournal.onlinelibrary.wiley.com\/doi\/10.2903\/j.efsa.2014.3839\" target=\"_blank\" rel=\"noopener\">wiley.com<\/a><\/li>\n<li>Health Canada. “List of Dietary Fibres Reviewed and Accepted by Health Canada’s Food Directorate.” <a href=\"https:\/\/www.canada.ca\/en\/health-canada\/services\/publications\/food-nutrition\/list-reviewed-accepted-dietary-fibres.html\" target=\"_blank\" rel=\"noopener\">canada.ca<\/a><\/li>\n<li>Business Research Insights. “Resistant Dextrin Market Report.” 2024 (accessed via Global Prebiotic Association compilation). <a href=\"https:\/\/www.businessresearchinsights.com\/market-reports\/resistant-dextrin-market-100208\" target=\"_blank\" rel=\"noopener\">businessresearchinsights.com<\/a><\/li>\n\n<\/ol>\n<\/div>\n<\/article>\n<\/div>\n\n<\/body><\/html>\n","protected":false},"featured_media":7997,"template":"","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"Resistant Dextrin Benefits: Evidence, Dosage and Uses","_seopress_titles_desc":"Learn what resistant dextrin does, which benefits are supported by evidence, and how to assess dosage, tolerance and sourcing.","_seopress_robots_index":""},"categories":[],"class_list":["post-7994","blogs","type-blogs","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.saigaoingredients.com\/es\/wp-json\/wp\/v2\/blogs\/7994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.saigaoingredients.com\/es\/wp-json\/wp\/v2\/blogs"}],"about":[{"href":"https:\/\/www.saigaoingredients.com\/es\/wp-json\/wp\/v2\/types\/blogs"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.saigaoingredients.com\/es\/wp-json\/wp\/v2\/media\/7997"}],"wp:attachment":[{"href":"https:\/\/www.saigaoingredients.com\/es\/wp-json\/wp\/v2\/media?parent=7994"}],"wp:term":[{"taxonomy":"categories","embeddable":true,"href":"https:\/\/www.saigaoingredients.com\/es\/wp-json\/wp\/v2\/categories?post=7994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}